The fourth IACT review meeting took place on October 25-26, 2017 in London, United Kingdom....
Corporate Headquarters
C/ Ferraz 78- 2º Izqda
28008 Madrid
40.425846x-3.717027:16
Latest News
|
LeadArtis participates in the fourth Immunostimulatory Agonist Antibodies for Cancer Therapy (IACT) meeting in London (UK)
31-10-2017
|
LeadArtis discloses ATTACK, a novel bispecific T cell-recruiting antibody approach for cancer immunotherapy
15-01-2018
LeadArtis´scientists, in collaboration with other prime... |
Leadartis successfully accomplishes the TERET project
07-04-2017
Leadartis is proud to announce the successful conclusion of the TERET (New Treatments for... |
